methotrexate has been researched along with Pemphigoid in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.08) | 18.7374 |
1990's | 3 (6.25) | 18.2507 |
2000's | 10 (20.83) | 29.6817 |
2010's | 26 (54.17) | 24.3611 |
2020's | 8 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chang, MS; Chen, ST; Otto, TS; Reynolds, KL; Shi, CR; Thompson, LL | 1 |
Bahadoran, P; Dugourd, PM; Montaudié, H; Passeron, T; Sanchez, A; Velin, M | 1 |
Ahn, CS; Bowers, NL; Hrin, ML; Strowd, LC; Williams, JA | 1 |
Hsieh, CY; Tsai, TF | 1 |
Agarwal, A; Falcone, LM; James, AJ | 1 |
Lim, YL; Toh, JJ; Yew, YW | 1 |
Baniel, A; Gat, A; Hashimoto, T; Ishii, N; Matz, H; Shehadeh, W; Slutsky Bank, E; Sprecher, E; Zeeli, T | 1 |
Fisch, A; Gallais Sérézal, I; Johnell, K; Morin, L; Talme, T | 1 |
Kluger, N; Panelius, J; Pankakoski, A; Salava, A | 1 |
Binois, R; De Muret, A; Esteve, E; Gaboriaud, P; Gheit, T; Kerdraon, R; Nadal, M; Samimi, M; Tommasino, M; Touze, A | 1 |
Geller, S; Kremer, N; Sprecher, E; Zeeli, T | 1 |
Borda, LJ; Milikowski, C; Ross, A; Villada, G | 1 |
Assikar, S; Bedane, C; Dalmay, F; Delaumenie, S; Matei, I; Prudhomme, R; Souyri, N | 1 |
Tsai, TF; Wang, TS | 1 |
Hertl, M; Schmidt, T | 1 |
Bakker, CV; Jonkman, MF; Pas, HH; Terra, JB | 1 |
Delaplace, M; Estève, E; Raffin, D; Roussel, A | 1 |
Borradori, L; Joly, P | 1 |
Bakker, CV; Jonkman, MF; Terra, JB | 1 |
Cao, W; Ge, L; Li, W; Si, X; Sun, X; Xin, H | 1 |
Benayoun, E; Chosidow, O; Delyon, J; Moroch, J; Ortonne, N; Sbidian, E; Wolkenstein, P | 1 |
Ayala-Cortés, AS; Martínez-Cabriales, SA; Ocampo-Candiani, J; Rosales-Solis, G; Vázquez-Martínez, O; Welsh, O | 1 |
Kalińska-Bienias, A; Kowalewski, C; Lesniewska, A; Schwartz, R; Wozniak, K | 1 |
Balestri, R; Bardazzi, F; Infusino, SD; Magnano, M; Odorici, G; Patrizi, A | 1 |
Korman, N; Patton, T | 1 |
Ahmed, AR; Gürcan, HM | 1 |
Bénéton-Benhard, N | 1 |
Chosidow, O; Ingen-Housz-Oro, S; Ortonne, N; Roujeau, JC; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
Guillot, B; Kluger, N; Navarro, R; Pallure, V | 1 |
Bernard, P; Dereure, O; Du-Thanh, A; Estève, E; Guillot, B; Ingen-Housz-Oro, S; Joly, P; Maillard, H; Merlet, S; Pauwels, C; Richard, MA | 1 |
Borradori, L; Daniel, BS; Hall, RP; Murrell, DF | 1 |
Jorizzo, JL; Kwatra, SG | 1 |
Ermertcan, AT; Gunay, U; Gunduz, K; Kandiloğlu, AR | 1 |
André, C; Chosidow, O; Hue, S; Ingen-Housz-Oro, S; Le Saché-de Peufeilhoux, L; Ortonne, N; Roujeau, JC; Sbidian, E; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
Al Mebayadh, M; Cosnes, A; Ortonne, N; Valeyrie-Allanore, L | 1 |
Duong, B; Marks, S; Sami, N; Theos, A | 1 |
Bessis, D; Dereure, O; Guilhou, JJ; Guillot, B | 1 |
Bara, C; Briand, N; Celerier, P; Maillard, H | 1 |
Dahlman-Ghozlan, K; Heilborn, JD; Ortonne, JP; Stephansson, E | 1 |
Glinska-Wielochowska, M; Hashimoto, T; Ishii, N; Kowalewski, C; Schwartz, RA; Wozniak, K | 1 |
Héliot-Hostein, I; Seneschal, J; Taieb, A | 1 |
Bahadoran, P; Dahlman-Ghozlan, K; Ortonne, JP; Spadafora, A; Stephansson, E | 1 |
Berg, P; Eriksson, H; Kjellman, P | 1 |
Fleischer, AB; Jorizzo, JL; Paul, MA; White, WL | 1 |
Bauer, R; Böhm, I | 1 |
Albertioni, F; Heilborn, JD; Peterson, C; Ståhle-Bäckdahl, M; Stephansson, E; Vassilaki, I | 1 |
Dahlman-Ghozlan, K; Heilborn, JD; Stephansson, E | 1 |
Schaumburg-Lever, G | 1 |
4 review(s) available for methotrexate and Pemphigoid
Article | Year |
---|---|
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biological Factors; Biological Products; Cyclosporins; Dermatologic Agents; Etanercept; Humans; Immunosuppressive Agents; Methotrexate; Niacinamide; Pemphigoid, Bullous; Psoriasis; Rituximab; Ustekinumab; Vitamins | 2022 |
Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Methotrexate; Pemphigoid, Bullous; Pemphigus; Severity of Illness Index; Treatment Outcome | 2009 |
[Bullous pemphigoid].
Topics: Anti-Inflammatory Agents; Autoantigens; Clobetasol; Collagen Type XVII; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Direct; France; Histological Techniques; Humans; Immunoglobulin G; Immunosuppressive Agents; Karnofsky Performance Status; Methotrexate; Mycophenolic Acid; Non-Fibrillar Collagens; Patient Care Team; Pemphigoid, Bullous; Prognosis; Risk Factors | 2010 |
Evidence-based management of bullous pemphigoid.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Autoantibodies; Azathioprine; Clinical Trials as Topic; Dermatologic Agents; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Niacinamide; Pemphigoid, Bullous; Randomized Controlled Trials as Topic | 2011 |
2 trial(s) available for methotrexate and Pemphigoid
Article | Year |
---|---|
Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18 cases.
Topics: Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prospective Studies; Steroids; Treatment Outcome | 2002 |
Methotrexate for bullous pemphigoid: preliminary study.
Topics: Aged; Aged, 80 and over; Dermatologic Agents; Female; Humans; Male; Methotrexate; Pemphigoid, Bullous | 2003 |
42 other study(ies) available for methotrexate and Pemphigoid
Article | Year |
---|---|
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid.
Topics: Drug Eruptions; Humans; Immune Checkpoint Inhibitors; Immunosuppressive Agents; Methotrexate; Pemphigoid, Bullous; Retrospective Studies | 2021 |
Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real-life study.
Topics: Antibodies, Monoclonal, Humanized; Humans; Methotrexate; Omalizumab; Pemphigoid, Bullous; Steroids | 2022 |
Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic.
Topics: Ambulatory Care Facilities; Dermatology; Humans; Methotrexate; Mouth Mucosa; Mucous Membrane; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous | 2022 |
Methotrexate-induced hypersensitivity pneumonitis in a patient with bullous pemphigoid.
Topics: Alveolitis, Extrinsic Allergic; Drug Hypersensitivity; Humans; Methotrexate; Pemphigoid, Bullous; Prednisone | 2023 |
Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cyclosporine; Disease Management; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigoid, Bullous; Pemphigus; Psoriasis; Retrospective Studies; Ultraviolet Therapy | 2019 |
Bullous pemphigoid distributed above the injury level in a paraplegic patient.
Topics: Biopsy; Dermatologic Agents; Female; Humans; Methotrexate; Middle Aged; Paraplegia; Pemphigoid, Bullous; Spinal Cord Injuries; Treatment Outcome | 2020 |
Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Humans; Methotrexate; Pemphigoid, Bullous; Renal Insufficiency; Retrospective Studies | 2020 |
Bullous Pemphigoid in Three Paediatric Patients in Finland.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Child, Preschool; Collagen Type XVII; Dermatologic Agents; Female; Finland; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infliximab; Male; Methotrexate; Non-Fibrillar Collagens; Pemphigoid, Bullous; Prednisolone | 2020 |
Cutaneous Kaposi sarcoma during treatment with superpotent topical steroids and methotrexate for bullous pemphigoid: three cases.
Topics: Administration, Cutaneous; Aged; Clobetasol; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methotrexate; Pemphigoid, Bullous; Sarcoma, Kaposi; Skin Neoplasms | 2017 |
Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Head; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Immunosuppressive Agents; Male; Metformin; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tetracycline; Treatment Failure | 2017 |
Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia.
Topics: Aged; Drug Eruptions; Eosinophilia; Female; Humans; Leucovorin; Methotrexate; Mouth Mucosa; Pancytopenia; Pemphigoid, Bullous; Treatment Outcome | 2018 |
Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.
Topics: Aged, 80 and over; Autoantibodies; Autoantigens; Clobetasol; Collagen Type XVII; Dermatologic Agents; Drug Therapy, Combination; Dystonin; Humans; Methotrexate; Non-Fibrillar Collagens; Pemphigoid, Bullous; Retrospective Studies; Time Factors | 2019 |
Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Induction Chemotherapy; Male; Methotrexate; Pemphigoid, Bullous; Prednisolone; Psoriasis; Rituximab | 2014 |
Underrecognition of the heterogeneous clinical spectrum of bullous pemphigoid.
Topics: Female; Glucocorticoids; Humans; Male; Methotrexate; Pemphigoid, Bullous; Pruritus | 2013 |
Bullous pemphigoid as pruritus in the elderly: a common presentation.
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Aged, 80 and over; Delayed Diagnosis; Dermatologic Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Pruritus; Remission Induction; Time Factors; Treatment Outcome | 2013 |
[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Topics: Aged; Autoantibodies; Autoantigens; Clobetasol; Dapsone; Drug Resistance; Humans; Immunoglobulin G; Immunosuppressive Agents; Laminin; Male; Methotrexate; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Prednisolone; Remission Induction; Skin | 2013 |
Toward a practical renaming of bullous pemphigoid and all its variants: cutaneous pemphigoid.
Topics: Female; Glucocorticoids; Humans; Male; Methotrexate; Pemphigoid, Bullous; Pruritus | 2014 |
Toward a practical renaming of bullous pemphigoid and all its variants-reply.
Topics: Female; Glucocorticoids; Humans; Male; Methotrexate; Pemphigoid, Bullous; Pruritus | 2014 |
Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin.
Topics: Aged; Biopsy; Dermatitis, Exfoliative; Dermatologic Agents; Drug Therapy, Combination; Glycyrrhizic Acid; Humans; Male; Methotrexate; Microscopy, Fluorescence; Pemphigoid, Bullous; Psoriasis; Skin; Treatment Outcome | 2014 |
Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
Topics: Administration, Oral; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Biomarkers; Biopsy, Needle; Cohort Studies; Dose-Response Relationship, Drug; Drug Eruptions; Female; Follow-Up Studies; Humans; Immunohistochemistry; Keratinocytes; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Psoriasis; Rare Diseases; Retrospective Studies; Risk Assessment; Skin Ulcer | 2015 |
Childhood Bullous Pemphigoid: A Treatment Challenge.
Topics: Adolescent; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Male; Methotrexate; Pemphigoid, Bullous; Prednisone | 2016 |
Development of bullous pemphigoid in a patient with psoriasis and metabolic syndrome.
Topics: Adult; Autoantibodies; Dose-Response Relationship, Drug; Dystonin; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Metabolic Syndrome; Methotrexate; Pemphigoid, Bullous; Psoriasis; Treatment Outcome | 2016 |
Survey of bullous pemphigoid in an Italian university hospital: clinical-epidemiological characteristics and follow-up.
Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Eosinophilia; Female; Follow-Up Studies; Glucocorticoids; Hospitals, University; Humans; Italy; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Retrospective Studies; Surveys and Questionnaires | 2018 |
Role of methotrexate in the treatment of bullous pemphigoid in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Clinical Trials as Topic; Dermatologic Agents; Humans; Methotrexate; Pemphigoid, Bullous | 2008 |
Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months.
Topics: Aged; Aged, 80 and over; Clobetasol; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lost to Follow-Up; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Compliance; Pemphigoid, Bullous; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
[Bullous pemphigoid and acquired haemophilia].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune Diseases; Clobetasol; Factor VIIa; Factor VIII; Hemophilia A; Hemorrhage; Humans; Immunosuppressive Agents; Male; Methotrexate; Pemphigoid, Bullous; Recombinant Proteins; Rituximab; Treatment Refusal | 2011 |
Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Retrospective Studies; Steroids; Treatment Outcome | 2011 |
Bullous pemphigoid: a case series with emphasis on long-term remission off therapy.
Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome | 2013 |
Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Dermatologic Agents; Female; Humans; Methotrexate; Pemphigoid, Bullous; Psoriasis; Remission Induction | 2013 |
The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Autoantibodies; Carrier Proteins; Clobetasol; Cytoskeletal Proteins; Dystonin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Membrane Glycoproteins; Methotrexate; Mycophenolic Acid; Nerve Tissue Proteins; Pemphigoid, Bullous; Sensitivity and Specificity; Treatment Outcome | 2012 |
[Methotrexate-induced cutaneous reactions: two case reports].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Drug Eruptions; Female; Humans; Injections, Subcutaneous; Male; Methotrexate; Pemphigoid, Bullous | 2012 |
Lichen planus pemphigoides in a 2-year-old girl: response to treatment with methotrexate.
Topics: Child, Preschool; Dermatologic Agents; Female; Humans; Lichen Planus; Methotrexate; Pemphigoid, Bullous; Treatment Outcome | 2012 |
Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Biopsy; E-Selectin; Gene Expression Regulation; Humans; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Methotrexate; Pemphigoid, Bullous; Skin; Vascular Cell Adhesion Molecule-1 | 2004 |
Penicillin-induced anti-p200 pemphigoid: an unusual morphology.
Topics: Autoantibodies; Autoimmune Diseases; Erythema; Female; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Pemphigoid, Bullous; Penicillins; Prednisone; Treatment Outcome | 2006 |
Pancytopenia induced by low-dose methotrexate in a haemodialysis patient treated for bullous pemphigoid.
Topics: Aged; Antirheumatic Agents; Diagnosis, Differential; Humans; Male; Methotrexate; Pancytopenia; Pemphigoid, Bullous; Renal Dialysis | 2007 |
Low-dose oral methotrexate induces apoptosis of tissue eosinophils in bullous pemphigoid.
Topics: Administration, Oral; Apoptosis; Biopsy; Eosinophils; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Methotrexate; Microscopy; Pemphigoid, Bullous; Skin | 2008 |
A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2008 |
Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Combinations; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Remission Induction; Retrospective Studies | 1994 |
[Treatment of bullous pemphigoid with low-dose methotrexate].
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Methotrexate; Pemphigoid, Bullous | 1997 |
Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Dermatologic Agents; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Pemphigoid, Bullous; Prednisone; Remission Induction; Safety | 1999 |
Circulating levels of soluble E-selectin, ICAM-1 and VCAM-1 in bullous pemphigoid during low-dose methotrexate therapy. A prospective study.
Topics: Aged; Aged, 80 and over; Blister; Dermatologic Agents; E-Selectin; Female; Humans; Intercellular Adhesion Molecule-1; Male; Methotrexate; Pemphigoid, Bullous; Prospective Studies; Solubility; Vascular Cell Adhesion Molecule-1 | 2000 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous; Pemphigus; Prednisone; Skin Diseases, Vesiculobullous | 1986 |